Institutional Ownership
Camp4 Therapeutics Corp
CUSIP 13463J101COMCAMPQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
19.4%
Max % of class reported
Institutional Holders
43
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest Mar 11, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 11, 2026 | Enavate Sciences Gp, LLC | 13D/A | 4.8% | — | SEC |
| 2 | Feb 13, 2026 | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 7.4% | 3.86M | SEC |
| 3 | Feb 5, 2026 | Fmr LLC | 13G/A | 9.5% | 4.92M | SEC |
| 4 | Jan 8, 2026 | Janus Henderson Group PLC | 13G | 12.2% | 6.31M | SEC |
| 5 | Dec 23, 2025 | Enavate Sciences Gp, LLC | 13D/A | 6.0% | — | SEC |
| 6 | Dec 11, 2025 | Coastlands Capital LP | 13G/A | 10.0% | — | SEC |
| 7 | Nov 14, 2025 | Northpond Ventures II, LP | 13G/A | 4.8% | 2.24M | SEC |
| 8 | Nov 14, 2025 | Ah Bio Fund I, L.P. | 13G/A | 4.5% | 2.13M | SEC |
| 9 | Nov 7, 2025 | Fmr LLC | 13G/A | 6.7% | 3.15M | SEC |
| 10 | Oct 7, 2025 | Fmr LLC | 13G | 15.0% | 3.02M | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Camp4 Therapeutics Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 6.31M | $27.88M |
| 2 | 5am Venture Management, LLC | 5.87M | $25.88M |
| 3 | Fmr LLC | 4.93M | $21.76M |
| 4 | Vivo Capital, LLC | 4.25M | $18.73M |
| 5 | Balyasny Asset Management L.P. | 2.63M | $11.61M |
| 6 | Enavate Sciences Gp, LLC | 2.19M | $9.66M |
| 7 | A16z Capital Management, L.L.C. | 2.13M | $9.37M |
| 8 | Adage Capital Partners Gp, L.L.C. | 1.96M | $8.65M |
| 9 | Trails Edge Capital Partners, LP | 1.94M | $8.55M |
| 10 | Stonepine Capital Management, LLC | 1.39M | $6.13M |